Birmingham, West Midlands -- (SBWIRE) -- 12/20/2013 -- Value Penny Stocks issues special report on Novavax, Inc. (NASDAQ:NVAX), The Wendy's Co (NASDAQ:WEN), Huntington Bancshares Incorporated (NASDAQ:HBAN), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT).
Novavax, Inc. (NASDAQ:NVAX) ended its recent business day with the gain of 3.77% and closed at the price of $4.68 after opening at $4.58. The stock traded during its last trading session with the total volume of 6,399,936 shares, as compared to its average volume of 4.83 million shares. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
For How Long NVAX will Fight for Profitability? Read This Trend Analysis report
The Wendy's Co (NASDAQ:WEN) remained among the day advancers and traded with volume of 6,211,971 shares in the last session, as compared to average volume of 7.67 million shares. In comparison with 52 week range of $4.60 - $9.51, it faced lowest price of $8.34 during the last trading session whereas its day highest price was $8.49. The company’s total market capitalization is $3.31 billion, along with 391.68 million shares outstanding. The Wendy’s Company, through its subsidiaries, owns and franchises Wendy’s restaurant system in North America and internationally. It engages in operating, developing, and franchising a system of distinctive quick-service restaurants.
For How Long WEN’s Gloss will Attract Investors? Find out via this report
Huntington Bancshares Incorporated (NASDAQ:HBAN) showed 6,164,081 shares in volume during the last trading session, while the average trading volume remained 9.51 million shares. The stock kicked off its trading session at $9.50 and closed at $9.55 after mounting 0.32%. Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services. The company’s Retail and Business Banking segment offers various financial products and services.
Will HBAN Continue To Move Higher? Find Out Here
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) stock traded during its last trading session with the total traded volume of 6,163,162 shares versus its average volume of 2.96 million shares. The company opened its trade at the price of $4.35 and its closing price was $5.05 after gaining 18.54% for the day. Oxygen Biotherapeutics, Inc., a development stage company, engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States. It develops Oxycyte, a systemic perfluorocarbon based oil in water emulsion oxygen carrier for use in situations of acute ischemia; and is in Phase II-b clinical trial for the treatment of traumatic brain injury.
Why Should Investors Buy OXBT After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)